Swiss National Bank’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.8M | Sell |
266,431
-10,100
| -4% | -$372K | 0.01% | 929 |
|
2025
Q1 | $9.78M | Buy |
276,531
+46,600
| +20% | +$1.65M | 0.01% | 912 |
|
2024
Q4 | $10.1M | Buy |
229,931
+4,400
| +2% | +$192K | 0.01% | 945 |
|
2024
Q3 | $10.2M | Sell |
225,531
-1,300
| -0.6% | -$59K | 0.01% | 925 |
|
2024
Q2 | $8.8M | Buy |
226,831
+26,700
| +13% | +$1.04M | 0.01% | 961 |
|
2024
Q1 | $6.45M | Hold |
200,131
| – | – | ﹤0.01% | 1135 |
|
2023
Q4 | $5.74M | Buy |
200,131
+36,531
| +22% | +$1.05M | ﹤0.01% | 1208 |
|
2023
Q3 | $4.53M | Buy |
163,600
+1,800
| +1% | +$49.8K | ﹤0.01% | 1334 |
|
2023
Q2 | $4.33M | Sell |
161,800
-6,800
| -4% | -$182K | ﹤0.01% | 1397 |
|
2023
Q1 | $3.65M | Buy |
168,600
+20,300
| +14% | +$440K | ﹤0.01% | 1453 |
|
2022
Q4 | $3.53M | Buy |
148,300
+6,000
| +4% | +$143K | ﹤0.01% | 1527 |
|
2022
Q3 | $2.81M | Buy |
142,300
+38,100
| +37% | +$751K | ﹤0.01% | 1641 |
|
2022
Q2 | $2.03M | Sell |
104,200
-9,000
| -8% | -$175K | ﹤0.01% | 1906 |
|
2022
Q1 | $2.89M | Buy |
113,200
+7,700
| +7% | +$196K | ﹤0.01% | 1809 |
|
2021
Q4 | $2.66M | Hold |
105,500
| – | – | ﹤0.01% | 1873 |
|
2021
Q3 | $2.9M | Buy |
105,500
+2,100
| +2% | +$57.8K | ﹤0.01% | 1808 |
|
2021
Q2 | $3.28M | Buy |
103,400
+57,900
| +127% | +$1.84M | ﹤0.01% | 1780 |
|
2021
Q1 | $2.09M | Buy |
45,500
+800
| +2% | +$36.7K | ﹤0.01% | 1976 |
|
2020
Q4 | $1.77M | Buy |
44,700
+8,500
| +23% | +$337K | ﹤0.01% | 1972 |
|
2020
Q3 | $1.26M | Buy |
36,200
+9,900
| +38% | +$345K | ﹤0.01% | 1960 |
|
2020
Q2 | $830K | Buy |
+26,300
| New | +$830K | ﹤0.01% | 2206 |
|